비자나무 정유 추출물을 이용한 기능성 천연 향료 조성물
    102.
    发明公开
    비자나무 정유 추출물을 이용한 기능성 천연 향료 조성물 有权
    具有特征性油提取物的功能性天然成分组合物

    公开(公告)号:KR1020140046200A

    公开(公告)日:2014-04-18

    申请号:KR1020120112367

    申请日:2012-10-10

    CPC classification number: A61K8/97 A61K8/046 A61Q13/00 A61Q19/10

    Abstract: Disclosed is a functional natural fragrance composition using an essential oil extract of Torreya nucifera. Specifically, disclosed is a functional natural fragrance composition using an essential oil extract of Torreya nucifera with antibacterial activity and anti-stress activity as an effective component. The functional natural fragrance composition has the antibacterial activity against Propionibacterium acne, which is an acne germ.

    Abstract translation: 本发明公开了一种功能性天然香料组合物,其使用了Torreya nucifera的精油提取物。 具体地说,公开了一种功能性天然香料组合物,其使用具有抗菌活性和抗应激活性的Torreya nucifera精油提取物作为有效成分。 功能性天然香料组合物对痤疮丙酸杆菌具有抗菌活性,这是痤疮细菌。

    경단구슬모자반 추출물을 이용한 고지혈증 개선용 조성물
    107.
    发明公开
    경단구슬모자반 추출물을 이용한 고지혈증 개선용 조성물 有权
    使用AN AN AN FOR FOR FOR。。。。。。。。。。。。。。

    公开(公告)号:KR1020130083265A

    公开(公告)日:2013-07-22

    申请号:KR1020120003944

    申请日:2012-01-12

    Abstract: PURPOSE: An anti-obesity composition using a Sargassum muticum extract is provided to be used as an anti-obesity composition, a hyperlipidemia treatment composition, and a fatty acid treatment composition and to manufacture foods or pharmaceutical products. CONSTITUTION: An anti-obesity composition contains a Sargassum muticum extract as an active ingredient. The extract is prepared using water, ethanol, or a mixture thereof. A hyperlipidemia treatment composition contains the extract as an active ingredient. A fatty liver treatment composition contains the extract as an active ingredient. A diet composition contains the extract as an active ingredient.

    Abstract translation: 目的:提供使用马齿苋提取物的抗肥胖组合物作为抗肥胖组合物,高脂血症治疗组合物和脂肪酸处理组合物,并用于制造食品或药品。 构成:抗肥胖组合物含有马齿苋提取物作为活性成分。 使用水,乙醇或其混合物制备提取物。 高脂血症治疗组合物含有作为活性成分的提取物。 脂肪肝处理组合物含有提取物作为活性成分。 饮食组合物含有提取物作为活性成分。

    참다래 과실 발효물을 이용한 항염증제 조성물 및 피부 미백제 조성물
    108.
    发明公开
    참다래 과실 발효물을 이용한 항염증제 조성물 및 피부 미백제 조성물 有权
    使用发酵产品的脱脂组合物和皮肤白化组合物

    公开(公告)号:KR1020130073179A

    公开(公告)日:2013-07-03

    申请号:KR1020110140888

    申请日:2011-12-23

    Abstract: PURPOSE: An anti-inflammatory composition and a skin whitening composition using a kiwi fruit fermentation are provided to suppress NO, PGE2, and inflammatory cytokine generation, and melanogenesis. CONSTITUTION: An anti-inflammatory composition contains a kiwi fruit fermentation which is prepared by inoculating lactic acid bacteria and yeast to a crushed kiwi fruit and fermenting. Sugar is added to the crushed kiwi fruit as an energy source. The lactic acid bacteria and the yeast are Lactobacillus plantarum and Saccharomyces cerevisiae. The composition is a pharmaceutical composition, a food composition, or a cosmetic composition.

    Abstract translation: 目的:提供使用猕猴桃发酵的抗炎组合物和皮肤美白组合物,以抑制NO,PGE2和炎性细胞因子的产生以及黑素生成。 构成:抗炎组合物含有猕猴桃发酵,其通过将乳酸菌和酵母接种到破碎的猕猴桃中并发酵而制备。 糖被添加到被碾碎的猕猴桃作为能源。 乳酸菌和酵母是植物乳杆菌(Lactobacillus plantarum)和酿酒酵母(Saccharomyces cerevisiae)。 组合物是药物组合物,食品组合物或化妆品组合物。

    블라디놀 F를 이용한 항염증성 조성물
    109.
    发明公开
    블라디놀 F를 이용한 항염증성 조성물 无效
    使用VLADINOL F的抗炎组合物

    公开(公告)号:KR1020130071666A

    公开(公告)日:2013-07-01

    申请号:KR1020110139005

    申请日:2011-12-21

    CPC classification number: A61K36/60 A61K31/12

    Abstract: PURPOSE: An anti-inflammatory composition using vladinol F isolated from F. erecta var. sieboldii is provided to suppress generation of NO, PGE2 (prostaglandin), and inflammatory cytokines (TNF-alpha, IL-1beta, and IL-6). CONSTITUTION: An anti-inflammatory composition contains vladinol F as an active ingredient. A method for isolating vladinol F from F. erecta var. sieboldii comprises the steps of: dipping F. erecta var. sieboldii leaves, stems, or a mixture thereof in a mixture solvent of ethanol and water and preparing a power extract; suspending the extract in distilled water, and sequentially fractioning to obtain a dichloromethane fraction; coating a celite surface with the fraction and performing column chromatography using hexane, dichloromethane, ethyl acetate, and methanol to obtain 4 purified materials; performing normal phase column chromatography of a second purified material using hexane:ethyl acetate:methanol (1:2:0.2, v/v) to obtain total 20 purified materials; performing normal phase silicagel column chromatography of 16th purified material among 20 purified materials using chloroform:methanol (10:1, v/v) and preparing total 18 purified materials; and collecting 9th purified material among 18 purified materials. [Reference numerals] (AA) MC fraction of a F. erecta var. sieboldii extract (11.2g); (BB) Column chromatography; (CC) Normal phase silica gel (5cm×60cm); (DD) Normal phase silica gel (2.0cm×50cm)

    Abstract translation: 目的:使用从F. erecta var。分离的vladinol F的抗炎组合物。 提供sieboldii以抑制NO,PGE2(前列腺素)和炎性细胞因子(TNF-α,IL-1β和IL-6)的产生。 构成:抗炎组合物含有vladinol F作为活性成分。 一种从F. erecta var。中分离vladinol F的方法。 sieboldii包括以下步骤:浸渍F.frecta var。 sieboldii叶,茎或其在乙醇和水的混合溶剂中的混合物,并制备动力提取物; 将提取物悬浮在蒸馏水中,并依次分级得到二氯甲烷馏分; 用级分涂覆硅藻土表面,并使用己烷,二氯甲烷,乙酸乙酯和甲醇进行柱层析,得到4种纯化物; 使用己烷:乙酸乙酯:甲醇(1:2:0.2,v / v)进行第二纯化物质的正相柱色谱,得到总共20种纯化物质; 使用氯仿:甲醇(10:1,v / v)在20个纯化物中进行第16次纯化物质的正相硅胶柱色谱,并制备总共18种纯化物质; 并在18种纯化材料中收集第9种纯化材料。 (参考数字)(AA)MC分数F.frecta var。 sieboldii提取物(11.2g); (BB)柱色谱; (CC)正相硅胶(5cm×60cm); (DD)正相硅胶(2.0cm×50cm)

Patent Agency Ranking